Last reviewed · How we verify
NCT05461625
ACL Reconstruction With/Without ALL Reconstruction
NA trial testing ACL reconstruction in ACL Injury in 762 participants. Status unknown.
1 September 2024
Quick facts
| Lead sponsor | Centre of Postgraduate Medical Education |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 762 |
| Start date | 1 September 2021 |
| Primary completion | 1 September 2024 |
| Estimated completion | 1 December 2024 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- ACL reconstruction
- ALL anatomic
- ALL tenodesis
Conditions studied
- ACL Injury — all drugs for ACL Injury →
- ALL — all drugs for ALL →
Sponsor
Centre of Postgraduate Medical Education — full company profile →
Who can join
Adults 18 to 65, any sex, with ACL Injury or ALL. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will compare Anterior Cruciate Reconstruction with or without Anterolateral Ligament Reconstruction in patients with ACL injury. The purpose of this study is evaluate if addition of ALLr to ACLr provides better clinical, radiological and laboratory outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05461625
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of ACL reconstruction
Trials testing the same drug.
- NCT07506304 — Biological Potentials in Arthroscopic All-inside Semitendinosus Anterior Cruciate Ligament Reconstruction · NA · not yet recruiting
- NCT06167343 — Comparison of Semitendinosus and Quadriceps Grafts for Anterior Cruciate Ligament Reconstruction · NA · active not recruiting
- NCT05504018 — Clinical and Radiological Evaluation of ACL Reconstruction Results · NA · completed
- NCT05582226 — Augmentation of Anterior Cruciate Ligament Reconstruction Using Mesenchymal Stem Cells and Collagen Matrix Carrier · NA · unknown
- NCT05876013 — Reduced Knee Flexion Strength 18 Years After ACL Reconstruction in Hamstring Group Compared to Patellar Tendon Group · completed
Other recruiting trials for ACL Injury
Currently open trials in the same condition.
- NCT06529679 — Michigan Split-belt Treadmill Training Program to Improve Acute Knee Biomechanics After ACL Reconstruction · NA · recruiting
- NCT06442319 — The Efficiency and Safety of PRP Treatment After Anterior Cruciate Ligament Reconstruction. · NA · recruiting
- NCT06524869 — Association Between Neuromuscular Parameters and Functional Assessment After ACL Reconstruction · recruiting
- NCT07387939 — ACL Reconstruction in Patients Aged 50 Years and Older · active not recruiting
- NCT06194682 — Anterior Cruciate Ligament Study · recruiting
Other Centre of Postgraduate Medical Education trials
Trials by the same sponsor.
- NCT07358299 — Haemodynamic Effects and Complications of Continuous Versus Single-shot Spinal Anaesthesia for HIP Fracture Surgery · Phase 4 · not yet recruiting
- NCT07197398 — Preoperative Data and the Spinal Spread of Local Anesthetic in Cesarean Section · recruiting
- NCT06741410 — Ephedrine Versus Phenylephrine for Spinal Block - Related Hypotension in Cesarean Delivery · completed
- NCT06418516 — Early Detection of Esophageal Squamous Cancer With the Capsule Sponge Device · NA · not yet recruiting
- NCT06472102 — Cardioneuroablation: Fragmented Atrial Potentials, Intracardiac Echocardiography and Computed Tomography · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05461625 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre of Postgraduate Medical Education
- Last refreshed: 18 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05461625.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing